239 related articles for article (PubMed ID: 30102821)
1. Platelet count and platelet-lymphocyte ratio as prognostic markers for head and neck squamous cell carcinoma: Meta-analysis.
Takenaka Y; Oya R; Kitamiura T; Ashida N; Shimizu K; Takemura K; Yamamoto Y; Uno A
Head Neck; 2018 Dec; 40(12):2714-2723. PubMed ID: 30102821
[TBL] [Abstract][Full Text] [Related]
2. Prognostic role of neutrophil-to-lymphocyte ratio in head and neck cancer: A meta-analysis.
Takenaka Y; Oya R; Kitamiura T; Ashida N; Shimizu K; Takemura K; Yamamoto Y; Uno A
Head Neck; 2018 Mar; 40(3):647-655. PubMed ID: 29076207
[TBL] [Abstract][Full Text] [Related]
3. High pretreatment neutrophil-to-lymphocyte ratio as a predictor of poor survival prognosis in head and neck squamous cell carcinoma: Systematic review and meta-analysis.
Yang L; Huang Y; Zhou L; Dai Y; Hu G
Head Neck; 2019 May; 41(5):1525-1535. PubMed ID: 30597654
[TBL] [Abstract][Full Text] [Related]
4. Presurgical platelet-lymphocyte ratio for prognosis in advanced hypopharyngeal squamous cell carcinoma in individuals undergoing radical resection.
Chen H; Song S; Li A; Ma D; Lin C; Qian X; Gao X; Shen X
Acta Otolaryngol; 2021 May; 141(5):537-543. PubMed ID: 33872102
[TBL] [Abstract][Full Text] [Related]
5. The prognostic value of pretreatment platelet count in patients with head and neck squamous cell carcinoma.
Pardo L; Valero C; López M; García J; Camacho M; Quer M; León X
Auris Nasus Larynx; 2017 Jun; 44(3):313-318. PubMed ID: 27401121
[TBL] [Abstract][Full Text] [Related]
6. Platelet-Lymphocyte Ratio as a Predictor of Prognosis in Head and Neck Cancer: A Systematic Review and Meta-Analysis.
Bardash Y; Olson C; Herman W; Khaymovich J; Costantino P; Tham T
Oncol Res Treat; 2019; 42(12):665-677. PubMed ID: 31550732
[TBL] [Abstract][Full Text] [Related]
7. The prognostic role of platelet-to-lymphocyte ratio on overall survival in gastric cancer: a systematic review and meta-analysis.
Cao W; Yao X; Cen D; Zhi Y; Zhu N; Xu L
BMC Gastroenterol; 2020 Jan; 20(1):16. PubMed ID: 31959103
[TBL] [Abstract][Full Text] [Related]
8. Systemic inflammatory markers as independent prognosticators of head and neck squamous cell carcinoma.
Rassouli A; Saliba J; Castano R; Hier M; Zeitouni AG
Head Neck; 2015 Jan; 37(1):103-10. PubMed ID: 24339165
[TBL] [Abstract][Full Text] [Related]
9. Optimal cutoff of pretreatment neutrophil-to-lymphocyte ratio in head and neck cancer patients: a meta-analysis and validation study.
Cho JK; Kim MW; Choi IS; Moon UY; Kim MJ; Sohn I; Kim S; Jeong HS
BMC Cancer; 2018 Oct; 18(1):969. PubMed ID: 30309318
[TBL] [Abstract][Full Text] [Related]
10. Prognostic role of platelet to lymphocyte ratio in solid tumors: a systematic review and meta-analysis.
Templeton AJ; Ace O; McNamara MG; Al-Mubarak M; Vera-Badillo FE; Hermanns T; Seruga B; Ocaña A; Tannock IF; Amir E
Cancer Epidemiol Biomarkers Prev; 2014 Jul; 23(7):1204-12. PubMed ID: 24793958
[TBL] [Abstract][Full Text] [Related]
11. Sarcopenia with inflammation as a predictor of survival in patients with head and neck cancer.
Yamahara K; Mizukoshi A; Lee K; Ikegami S
Auris Nasus Larynx; 2021 Oct; 48(5):1013-1022. PubMed ID: 33883097
[TBL] [Abstract][Full Text] [Related]
12. THE PROGNOSTIC ROLE OF PRE-TREATMENT PLATELET-TO-LYMPHOCYTE RATIO IN HEAD AND NECK SQUAMOUS CELL CARCINOMA: META-ANALYSIS AND TRIAL SEQUENTIAL ANALYSIS.
Diana R; Pierluigi M; Dardo M; Claudia A; Rosario R; Luigi L
J Evid Based Dent Pract; 2023 Dec; 23(4):101898. PubMed ID: 38035889
[TBL] [Abstract][Full Text] [Related]
13. Survival and prognostic analysis of preoperative inflammatory markers in patients undergoing surgical resection for laryngeal squamous cell carcinoma.
Chen L; Zeng H; Yang J; Lu Y; Zhang D; Wang J; Kuang C; Zhu S; Wang M; Ma X
BMC Cancer; 2018 Aug; 18(1):816. PubMed ID: 30103707
[TBL] [Abstract][Full Text] [Related]
14. Relation of baseline neutrophil-to-lymphocyte ratio to survival and toxicity in head and neck cancer patients treated with (chemo-) radiation.
Bojaxhiu B; Templeton AJ; Elicin O; Shelan M; Zaugg K; Walser M; Giger R; Aebersold DM; Dal Pra A
Radiat Oncol; 2018 Nov; 13(1):216. PubMed ID: 30400969
[TBL] [Abstract][Full Text] [Related]
15. Prognostic role of platelet to lymphocyte ratio in pancreatic cancers: A meta-analysis including 3028 patients.
Li W; Tao L; Lu M; Xiu D
Medicine (Baltimore); 2018 Feb; 97(8):e9616. PubMed ID: 29465553
[TBL] [Abstract][Full Text] [Related]
16. Prognostic value of nutritional and hematologic markers in head and neck squamous cell carcinoma treated by chemoradiotherapy.
Moon H; Roh JL; Lee SW; Kim SB; Choi SH; Nam SY; Kim SY
Radiother Oncol; 2016 Feb; 118(2):330-4. PubMed ID: 26653356
[TBL] [Abstract][Full Text] [Related]
17. Prognostic significance of platelet-to-lymphocyte ratio in patients with ovarian cancer: A meta-analysis.
Tian C; Song W; Tian X; Sun Y
Eur J Clin Invest; 2018 May; 48(5):e12917. PubMed ID: 29469190
[TBL] [Abstract][Full Text] [Related]
18. Lower circulating platelet counts and antiplatelet therapy independently predict better outcomes in patients with head and neck squamous cell carcinoma.
Rachidi S; Wallace K; Day TA; Alberg AJ; Li Z
J Hematol Oncol; 2014 Sep; 7():65. PubMed ID: 25260646
[TBL] [Abstract][Full Text] [Related]
19. Neutrophil-to-lymphocyte ratio as a prognostic marker for head and neck squamous cell carcinoma treated with immune checkpoint inhibitors: Meta-analysis.
Takenaka Y; Oya R; Takemoto N; Inohara H
Head Neck; 2022 May; 44(5):1237-1245. PubMed ID: 35146824
[TBL] [Abstract][Full Text] [Related]
20. Increased platelet-lymphocyte ratio closely relates to inferior clinical features and worse long-term survival in both resected and metastatic colorectal cancer: an updated systematic review and meta-analysis of 24 studies.
Chen N; Li W; Huang K; Yang W; Huang L; Cong T; Li Q; Qiu M
Oncotarget; 2017 May; 8(19):32356-32369. PubMed ID: 28404961
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
